FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Propofol Injectable Emulsion Recall

Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion…

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Sep 5, 2012
Recall ID
D-1672-2012
Check your lot numberHow we source this data

Summary

Hospira recalled Propofol Injectable Emulsion starting Aug 3, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1672-2012 on Sep 5, 2012. Reason: Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.

Product description

Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-4699-24

Lot numbers, UPCs & expiration codes

07-893-DJ, exp. 7/2013, 10-123-DJ, 10-125-DJ, exp. 10/2013

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1672-2012
Classification
Class II
Status
Terminated
Recall initiated
Aug 3, 2012
FDA report date
Sep 5, 2012
Quantity
56,420 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-1672-2012, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
62999
Address
375 N Field Dr
Code information
07-893-DJ, exp. 7/2013, 10-123-DJ, 10-125-DJ, exp. 10/2013
Postal code
60045-2513
Report date
Sep 5, 2012
Product type
Drugs
Recall number
D-1672-2012
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
56,420 vials
Termination date
May 6, 2014
Reason for recall
Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-4699-24
Distribution pattern
Nationwide
Recall initiation date
Aug 3, 2012
Initial firm notification
Letter
Center classification date
Aug 30, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1672-2012, published Sep 5, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls